Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Asymptomatic Bacteriuria in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women ≥ 18 years of age seeking prenatal care at the Academic Obstetrics and Gynecology Center at St. Joseph Mercy Hospital, Ann Arbor, Michigan~* Randomization will occur if the patient every has a urine culture demonstrating ≥10,000 cfu/ml of a pathogenic urinary tract organism~Exclusion Criteria:~* Symptomatic bacteriuria (cystitis or pyelonephritis) at the time of urine collection~* Previously treated bacteriuria in current pregnancy~* Past medical history of known congenital or acquired urinary tract anomaly or abnormality (i.e. pelvic kidney, single kidney, renal transplant)~* Any antibiotic use within the week prior to urine sampling~* Urine culture revealing growth of the following organisms: Lactobacillus, coagulase-negative staphylococcus

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 3-day treatment (Type: EXPERIMENTAL): Three-day treatment with Cephalexin or Nitrofurantoin for diagnosis of asymptomatic bacteriuria in pregnancy.
- 7-day treatment (Type: ACTIVE_COMPARATOR): Seven-day treatment with Cephalexin or Nitrofurantoin for diagnosis of asymptomatic bacteriuria in pregnancy.

Based on this trial design, predict the completion outcome and termination type (if applicable).